PU.1 upregulation is linked to improved prognosis in non-small cell lung cancer

High expression of PU.1 associated with NK cells could lead to a beneficial outcome and survival of NSCLC patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-08-15
DOI
https://doi.org/10.3389/fimmu.2025.1604237
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PU.1 upregulation is linked to improved prognosis in non-small cell lung cancer

Denis I. Trufa, Horia Sı̂rbu, Sonja Trump, Susanne Mittler et al.
1 links
Frontiers in Immunology
RNA modifications and cancer
article

PU.1 upregulation is linked to improved prognosis in non-small cell lung cancer

Denis I. Trufa, Horia Sı̂rbu, Sonja Trump, Susanne Mittler, Susetta Finotto, Katja Hohenberger, Arndt Hartmann
article en

Abstract

High expression of PU.1 associated with NK cells could lead to a beneficial outcome and survival of NSCLC patients.

Frontiers in ImmunologyVol. 16
Universitätsklinikum Erlangen (DE), Comprehensive Cancer Center Erlangen (DE)
Deutsche Forschungsgemeinschaft, Universitätsklinikum Erlangen
Good health and well-being
Openalex Percentile: Top 81%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.